Literature DB >> 25603198

Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.

Eva M del Amo1, Kati-Sisko Vellonen2, Heidi Kidron3, Arto Urtti4.   

Abstract

The aims of this research were to (1) create a curated universal database of intravitreal volumes of distribution (Vss, ivt) and clearances (CL ivt) of small molecular weight compounds and macromolecules and (2) to develop quantitative structure property relationship (QSPR) and pharmacokinetic models for the estimation of vitreal drug concentrations based on the compound structure. Vss, ivt and CL ivt values were determined from the available literature on intravitreal drug administration using compartmental models and curve fitting. A simple QSPR model for CL ivt of small molecular weight compounds was obtained with two descriptors: Log D7.4 and hydrogen bond donor capacity. The model predicted the internal and external test sets reliably with a mean fold error of 1.50 and 1.33, respectively (Q(2)Y=0.62). For 80% of the compounds the Vss, ivt was 1.18-2.28 ml; too narrow range for QSPR model building. Integration of the estimated Vss, ivt and predicted CL ivt parameters into pharmacokinetic simulation models allows prediction of vitreous drug concentrations after intravitreal administration. The present work presents for the first time a database of CL ivt and Vss, ivt values and the dependence of the CL ivt values on the molecular structure. The study provides also useful in silico tools to investigate a priori the intravitreal pharmacokinetic profiles for intravitreally injected candidate compounds and drug delivery systems.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  1-heptanol; Amikacin; Ceftriaxone; Clearance; Dexamethasone phosphate; Erythromycin; Fluorouridine; Fomivirsen; Ganciclovir; Intravitreal injection; Ocular drug delivery; Oxacillin; Pharmacokinetic simulation; QSPR; Sulphacetamide; Tobramycin; Volume of distribution; Voriconazole

Mesh:

Substances:

Year:  2015        PMID: 25603198     DOI: 10.1016/j.ejpb.2015.01.003

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  32 in total

1.  Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.

Authors:  Maxime Le Merdy; Jianghong Fan; Michael B Bolger; Viera Lukacova; Jessica Spires; Eleftheria Tsakalozou; Vikram Patel; Lin Xu; Sharron Stewart; Ashok Chockalingam; Suresh Narayanasamy; Rodney Rouse; Murali Matta; Andrew Babiskin; Darby Kozak; Stephanie Choi; Lei Zhang; Robert Lionberger; Liang Zhao
Journal:  AAPS J       Date:  2019-05-20       Impact factor: 4.009

Review 2.  Interpenetrating polymeric network (IPNs) in ophthalmic drug delivery: Breaking the barriers.

Authors:  Sachin Rathod
Journal:  Int Ophthalmol       Date:  2022-09-02       Impact factor: 2.029

3.  Estimation of Intra-vitreal Half-Lifes in the Rabbit Eye with Semi-mechanistic Equations.

Authors:  Walter Schmitt
Journal:  Pharm Res       Date:  2016-09-14       Impact factor: 4.200

4.  Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.

Authors:  Xiao-Xiao Feng; Cheng Li; Wan-Wen Shao; Yong-Guang Yuan; Xiao-Bing Qian; Qi-Shan Zheng; Yu-Jie Li; Qian-Ying Gao
Journal:  Int J Ophthalmol       Date:  2018-03-18       Impact factor: 1.779

5.  Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization.

Authors:  Nader Sheibani; Shoujian Wang; Soesiawati R Darjatmoko; Debra L Fisk; Pawan K Shahi; Bikash R Pattnaik; Christine M Sorenson; Reshma Bhowmick; Olga V Volpert; Daniel M Albert; Ignacio Melgar-Asensio; Jack Henkin
Journal:  Exp Eye Res       Date:  2019-09-11       Impact factor: 3.467

Review 6.  Principles of pharmacology in the eye.

Authors:  Sahar Awwad; Abeer H A Mohamed Ahmed; Garima Sharma; Jacob S Heng; Peng T Khaw; Steve Brocchini; Alastair Lockwood
Journal:  Br J Pharmacol       Date:  2017-10-10       Impact factor: 8.739

7.  Assessment of the safety of intravitreal injection of metoprolol tartrate in rabbits.

Authors:  Mayara Rodrigues Brandão de Paiva; Raquel Gregório Arribada; Carolina Nunes da Silva; Marcela Coelho Silva Ribeiro; Rodrigo Jorge; Silvia Ligório Fialho; Armando Silva-Cunha
Journal:  Doc Ophthalmol       Date:  2020-07-04       Impact factor: 2.379

Review 8.  Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation.

Authors:  Felipe M González-Fernández; Annalisa Bianchera; Paolo Gasco; Sara Nicoli; Silvia Pescina
Journal:  Pharmaceutics       Date:  2021-03-26       Impact factor: 6.321

Review 9.  Peptidomimetics Therapeutics for Retinal Disease.

Authors:  Dylan E Parsons; Soo Hyeon Lee; Young Joo Sun; Gabriel Velez; Alexander G Bassuk; Mark Smith; Vinit B Mahajan
Journal:  Biomolecules       Date:  2021-02-24

10.  Permeability of the Retina and RPE-Choroid-Sclera to Three Ophthalmic Drugs and the Associated Factors.

Authors:  Hyeong Min Kim; Hyounkoo Han; Hye Kyoung Hong; Ji Hyun Park; Kyu Hyung Park; Hyuncheol Kim; Se Joon Woo
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.